Investing.com - Greenlight Biosciences Holdings PBC (NASDAQ: GRNA) reported first quarter EPS of $-0.190, $0.04 better than the analyst estimate of $-0.234. Revenue for the quarter came in at $3.82M versus the consensus estimate of $500K.
Greenlight Biosciences Holdings PBC's stock price closed at $0.240. It is down -71.430% in the last 3 months and down -97.300% in the last 12 months.
Greenlight Biosciences Holdings PBC saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Greenlight Biosciences Holdings PBC's stock price’s past reactions to earnings here.
According to InvestingPro, Greenlight Biosciences Holdings PBC's Financial Health score is "weak performance".
Check out Greenlight Biosciences Holdings PBC's recent earnings performance, and Greenlight Biosciences Holdings PBC's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar